For professionals in the chemical and pharmaceutical industries, understanding the properties and applications of key intermediates is fundamental to successful operations. Benzyloxy Ezetimibe, identified by its CAS number 163222-32-0, is one such critical compound. This article provides a detailed overview of its characteristics, its principal uses, and essential considerations for sourcing this intermediate effectively.

Chemical Identity and Properties:
Benzyloxy Ezetimibe, also known by synonyms such as Ezetimibe Benzyl Ether or (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone, is a synthetic organic compound. It is characterized by its off-white solid appearance. Key physical and chemical properties include:

• Molecular Formula: C31H27F2NO3
• Molecular Weight: Approximately 499.55 g/mol
• Purity: Typically specified at 95%min, with higher purities often available for specialized applications.
• Melting Point: Reported in the range of 176-178°C.
• Boiling Point: Approximately 706.5°C at 760 mmHg.
• Density: Around 1.27 g/cm³.
• Stability: It is generally stable under normal temperature and pressure conditions, making it suitable for storage and handling.

Principal Uses in Synthesis:
The primary role of Benzyloxy Ezetimibe is as a protected intermediate in the synthesis of Ezetimibe and its various derivatives. Ezetimibe is a widely prescribed medication used to lower cholesterol levels by inhibiting the absorption of cholesterol in the intestine. The benzyl group serves as a protecting agent for the phenolic hydroxyl group on the Ezetimibe molecule. This protection is vital during synthetic procedures, allowing chemists to perform reactions on other parts of the molecule without affecting the 4'-hydroxyl group. Once the desired modifications are complete, the benzyl protecting group can be removed through deprotection methods to reveal the active functional group.

This synthetic utility makes Benzyloxy Ezetimibe invaluable for:

• API Manufacturing: As a key intermediate in the commercial production of Ezetimibe.
• Drug Discovery: In the creation of novel Ezetimibe analogues with potentially enhanced efficacy, altered pharmacokinetics, or for targeting different physiological pathways.
• Research and Development: For academic and industrial chemists exploring new synthetic methodologies or developing complex organic molecules.

Sourcing Guide for Buyers:
When looking to purchase Benzyloxy Ezetimibe, several factors are crucial for ensuring a successful transaction. As a buyer, especially one seeking bulk quantities, consider the following:

• Supplier Reputation: Partner with established manufacturers and suppliers that have a track record of providing high-quality pharmaceutical intermediates. Look for companies that emphasize quality control and offer comprehensive documentation.
• Purity Specifications: Confirm that the purity level meets your specific project requirements. For pharmaceutical applications, high purity (e.g., 95%min or higher) is often mandatory.
• Pricing and Availability: Obtain quotes from multiple suppliers to ensure competitive pricing. Given its role as an intermediate, inquire about bulk pricing and lead times for larger orders. Manufacturers in China are often competitive sources for such chemicals.
• Technical Support and Documentation: Ensure that the supplier can provide a Certificate of Analysis (CoA) with each batch, as well as relevant Safety Data Sheets (SDS). Responsive technical support is also beneficial.
• Custom Synthesis Capabilities: If your needs extend beyond standard offerings, inquire about the supplier's custom synthesis capabilities for specialized derivatives or specific quality attributes.

In conclusion, Benzyloxy Ezetimibe is a sophisticated and essential intermediate for pharmaceutical synthesis. By understanding its properties and employing a diligent sourcing strategy, procurement professionals and R&D scientists can secure a reliable supply of this critical compound, thereby facilitating advancements in medicine and chemical innovation.